Skip to main content
. Author manuscript; available in PMC: 2006 Feb 3.
Published in final edited form as: Endocrinology. 2005 Sep 15;146(12):5247–5256. doi: 10.1210/en.2005-0472

TABLE 3.

cFLI of PVN-Par and PVN-Mag neuronal cell bodies and its percentage (expressed as percent CRH/cFLI), which is doubly labeled for CRH after i3cv administration of drugs

Treatment PVN-Par PVN-Mag % CRH/cFLI
Saline (n = 5) 22.4 ± 3.7 7.4 ± 0.7 5.4 ± 0.5
Leptin (3.0 μg, n = 5) 113.4 ± 26.0a 15.0 ± 2.9 69.6 ± 5.9c
MTII (0.05 μg, n = 6) 126.8 ± 22.5c 51.0 ± 10.1c,d 76.0 ± 3.5c,d
MTII (0.5 μg, n = 6) 181.0 ± 34.5b 58.5 ± 13.6c,d 76.8 ± 11.8c,d

Values are means ± sem expressed in grams.

a

P < 0.05;

b

P < 0.01;

c

P < 0.001 relative to saline treatment.

d

P < 0.05 relative to leptin treatment.